Dr. Redfern is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3075 Health Center Dr
Suite 102
San Diego, CA 92123Phone+1 858-637-7888Fax+1 858-637-7887
Education & Training
- University of California (San Francisco)/FresnoFellowship, Hematology and Medical Oncology, 1994 - 1996
- Johns Hopkins UniversityResidency, Internal Medicine, 1991 - 1994
- Johns Hopkins University School of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 1994 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013
Clinical Trials
- Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
Publications & Presentations
PubMed
- A phase 1 dose escalation of pritumumab in patients with refractory or recurrent gliomas or brain metastases.Jose Carrillo, Jaya Mini Gill, Charles Redfern, Ivan Babic, Natsuko Nomura
Neuro-Oncology Advances. 2024-09-30 - Repotrectinib in a Patient WithFusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.Karen M Yun, Anna Narezkina, Charles Redfern, Katherine Velasco, Lyudmila Bazhenova
JCO Precision Oncology. 2024-01-01 - 13 citationsPatient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blin...Fred Saad, Antoine Thiery-Vuillemin, Pawel Wiechno, Boris Alekseev, Nuria Sala
The Lancet. Oncology. 2022-10-01
Press Mentions
- Why Did Carter and McCain Have Such Different Brain Tumor Results?August 26th, 2018
Grant Support
- G Protein Signaling And Tissue ProliferationNational Cancer Institute1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: